Abstract
25Aug 2019 EFFECT OF NEOADJUVANT CHEMOTHERAPY ON HORMONE RECEPTOR (ER, PR) STATUS AND HER-2/NEU EXPRESSION IN INDIAN BREAST CANCER PATIENTS: A PROSPECTIVE STUDY. Saumya Singh , Vaibhav Jaiswal , Anand Kumar Mishra and Sandeep Tewari. Department of General Surgery; Department of Trauma Surgery; Department of Endocrine Surgery, King George`s Medical University, UP, Lucknow, India.
Highlights
(n=49) were Progesterone receptor (PR) before treatment which increased to 71.8% (n=51) post chemotherapy (p=0.99)
Change in expression of hormone receptor status was noticed, Estrogen Receptor (ER)+PR+ decreased to 25.4% (n=18), ERPR- increased to 69.0% (n=49), ER-PR + decreased to 2.8% (n=2), no change was noticed in ER+PR- status
Her-2/neu status changes on IHC staining after neoadjuvant chemotherapy (NACT)
Summary
EFFECT OF NEOADJUVANT CHEMOTHERAPY ON HORMONE RECEPTOR (ER, PR) STATUS AND HER-2/NEU EXPRESSION IN INDIAN BREAST CANCER PATIENTS: A PROSPECTIVE STUDY.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
